New Delhi (PTI): Sun Pharmaceutical Industries on Friday said it has received marketing approval from the US Food and Drug Administration for the abbreviated new drug application of its generic version of anti-cough drug Benzonatate.

"USFDA has granted approval for the abbreviated new drug application (ANDA) to market a generic version of Forest Labs Tessalon, Benzonatate capsules," the company said in a statement.

Benzonatate capsules, which has market of about 40 million dollars in the US, would be available in the market in two strengths of 100mg and 200mg, it said.

Sun Pharma said its drug is used to relieve cough due to the common cold, bronchitis, pneumonia and other lung infections.